Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHARP: Hydroxychloroquine for COVID-19 Prevention
NCT04342156Phase 3Withdrawn
- Sponsor
- Tan Tock Seng Hospital
- Start
- Apr 2020
- Primary completion
- Aug 2020
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of hydroxychloroquine in coronavirus disease 2019 (COVID-19), sponsored by Tan Tock Seng Hospital. Planned start Apr 2020; status: withdrawn.
02
Drugs
hydroxychloroquine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04342156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04342156.